为汽车制造提供“眼睛”的企业来了！下周两只新股可申购

Group 1: Company Overview - Yisiwei's IPO price is set at 7.67 CNY per share, focusing on machine vision equipment for the automotive manufacturing sector, providing solutions across various manufacturing processes [1] - The company is projected to achieve a market share of 13.7% in China's automotive manufacturing machine vision market and 22.5% in the overall automotive manufacturing sector by 2024, leading the industry [1] - Yisiwei has developed over ten products, covering six major manufacturing processes, establishing a comprehensive product range and application advantage, serving most domestic automotive manufacturers [1] Group 2: Business Growth and Financial Performance - From 2022 to 2024, Yisiwei's revenue is expected to grow from 22.3 million CNY to 39.2 million CNY, with a compound annual growth rate (CAGR) of 32.59%, while net profit is projected to increase from 5.39 million CNY to 84.43 million CNY, with a CAGR of 295.66% [2] - Aide Technology's IPO price is set at 55.95 CNY per share, focusing on orthopedic medical devices, including spinal, trauma, and sports medicine products [2] - The total fundraising amount for Aide Technology is 197.02 million CNY, aimed at expanding orthopedic consumables production, building a research center, and developing a marketing network [2] Group 3: Market Trends - The market size for orthopedic implant medical devices in China is expected to grow from 19.3 billion CNY in 2016 to 24.6 billion CNY by 2024, with a CAGR of 3.08%, despite a recent market contraction due to procurement policies [2] - Specific segments, such as the sports medicine market, continue to show growth despite overall market challenges [2]